Back to Search
Start Over
Central vagal afferent endings mediate reduction of food intake by melanocortin-3/4 receptor agonist.
- Source :
-
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2014 Sep 17; Vol. 34 (38), pp. 12636-45. - Publication Year :
- 2014
-
Abstract
- Injection of the melanocortin-3/4 receptor agonist melanotan-II (MTII) into the nucleus of the solitary tract (NTS) produces rapid and sustained reduction of food intake. Melanocortin-4 receptors (MC4Rs) are expressed by vagal afferent endings in the NTS, but it is not known whether these endings participate in MTII-induced reduction of food intake. In experiments described here, we evaluated the contribution of central vagal afferent endings in MTII-induced reduction of food intake. Examination of rat hindbrain sections revealed that neuronal processes expressing immunoreactivity for the endogenous MC4R agonist α-melanoctyte-stimulating hormone course parallel and wrap around anterogradely labeled vagal afferent endings in the NTS and thus are aptly positioned to activate vagal afferent MC4Rs. Furthermore, MTII and endogenous MC4R agonists increased protein kinase A (PKA)-catalyzed phosphorylation of synapsin I in vagal afferent endings, an effect known to increase synaptic strength by enhancing neurotransmitter release in other neural systems. Hindbrain injection of a PKA inhibitor, KT5720, significantly attenuated MTII-induced reduction of food intake and the increase in synapsin I phosphorylation. Finally, unilateral nodose ganglion removal, resulting in degeneration of vagal afferent endings in the ipsilateral NTS, abolished MTII-induced synapsin I phosphorylation ipsilateral to nodose ganglion removal. Moreover, reduction of food intake following MTII injection into the NTS ipsilateral to nodose ganglion removal was significantly attenuated, whereas the response to MTII was not diminished when injected into the contralateral NTS. Altogether, our results suggest that reduction of food intake following hindbrain MC4R activation is mediated by central vagal afferent endings.<br /> (Copyright © 2014 the authors 0270-6474/14/3312636-10$15.00/0.)
- Subjects :
- Animals
Carbazoles administration & dosage
Carbazoles pharmacology
Male
Microinjections
Nerve Endings physiology
Neurons, Afferent drug effects
Neurons, Afferent metabolism
Nodose Ganglion physiology
Peptides, Cyclic administration & dosage
Peptides, Cyclic antagonists & inhibitors
Phosphorylation
Protein Kinase Inhibitors administration & dosage
Protein Kinase Inhibitors pharmacology
Pyrroles administration & dosage
Pyrroles pharmacology
Rats
Receptor, Melanocortin, Type 4 metabolism
Solitary Nucleus physiology
Synapsins metabolism
Vagus Nerve physiology
alpha-MSH administration & dosage
alpha-MSH antagonists & inhibitors
alpha-MSH metabolism
alpha-MSH pharmacology
Eating drug effects
Eating physiology
Nerve Endings drug effects
Neurons, Afferent physiology
Peptides, Cyclic pharmacology
Receptor, Melanocortin, Type 4 agonists
Solitary Nucleus drug effects
Vagus Nerve drug effects
alpha-MSH analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1529-2401
- Volume :
- 34
- Issue :
- 38
- Database :
- MEDLINE
- Journal :
- The Journal of neuroscience : the official journal of the Society for Neuroscience
- Publication Type :
- Academic Journal
- Accession number :
- 25232103
- Full Text :
- https://doi.org/10.1523/JNEUROSCI.1121-14.2014